Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.86
-$0.55 (-4.10%)
At close: Oct 30, 2026, 4:00 PM ET
$12.86
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Revenue | n/a | n/a |
Cost of Revenue | n/a | n/a |
Gross Profit | n/a | n/a |
Operating Income | -121.37M | -84.66M |
Interest Income | 9.99M | 5.72M |
Pretax Income | -111.31M | -78.87M |
Net Income | -111.31M | -78.87M |
Selling & General & Admin | 20.31M | 13.79M |
Research & Development | 101.06M | 70.87M |
Other Expenses | n/a | n/a |
Operating Expenses | 121.37M | 84.66M |
Interest Expense | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 121.37M | 84.66M |
Income Tax Expense | n/a | n/a |
Shares Outstanding (Basic) | 102.23M | 117.95M |
Shares Outstanding (Diluted) | 102.23M | 117.95M |
EPS (Basic) | -1.09 | -0.67 |
EPS (Diluted) | -1.09 | -0.67 |
EBITDA | -111.31M | -84.56M |
EBIT | -111.31M | -84.66M |
Depreciation & Amortization | n/a | 101K |
Add to Watchlist
Select watchlists to add or remove KLRA